MicroRNA-based therapy: A new dimension in epilepsy treatment

International Journal of Neuroscience

Volumn 123, Issue 9, 2013, Pages 617-622

  Liu, Hao ^a   Roy, Mridul ^b   Tian, Fa Fa ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Epileptic seizure; Inflammation in brain; MicroRNA; Neurodegeneration; Treatments of epilepsy

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYCLOOXYGENASE 2; DICER; INTERLEUKIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MICRORNA; MICRORNA 132; MICRORNA 146A; MICRORNA 34A; N METHYL DEXTRO ASPARTIC ACID; TOLL LIKE RECEPTOR;

ARTICLE; BRAIN REGION; CALCIUM TRANSPORT; DOWN REGULATION; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; GENE EXPRESSION; GENE OVEREXPRESSION; HIPPOCAMPAL SCLEROSIS; HUMAN; NEGATIVE FEEDBACK; NONHUMAN; SIGNAL TRANSDUCTION; TEMPORAL LOBE EPILEPSY; UPREGULATION;

ANIMALS; CYTOKINES; EPILEPSY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; MICRORNAS;

EID: 84882336259     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.789513     Document Type: Article

References (63)

1. Fisher RS, van Emde BW, Blume W, et al. Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470-2
2. Baker GA, Jacoby A, Buck D, et al. Quality of life of people with epilepsy: A European Study. Epilepsia 1997;38:353-62
3. Chang BS, Lowenstein DH. Epilepsy. N Engl J Med 2003;349:1257-66
4. Cavanna AE, Cavanna S, Cavanna A. Epileptic seizures and sprit possession in Haitian culture: A report of four cases and review of the literature. Epilepsy Behav 2010;19:89-91
5. Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. Lancet 2006;367:1087-100
6. WHO Media Center. Epilepsy [Internet]. Available from: Http://www.who.int/mediacentre/factsheets/fs999/en [last accessed 22 Nov 2012].
7. Browne TR, Holmes GL. Epilepsy: Definitions and Background. In: A hand book of epilepsy. 4th ed. New York: Lippincott Williams and Wilkins; 2008: 2-3
8. Lhatoo SD, Johnson AL, Goodridge DM, et al. Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-Term, prospective, population-based cohort. Ann Neurol 2001;49:336-44
9. Gaitatzis A, Johnson AL, Chadwick DW, et al. Life expectancy in people with newly diagnosed epilepsy. Brain 2004;127:2427-32
10. Hitiris N, Mohanraj R, Norrie J, Brodie MJ. Mortality in epilepsy. Epilepsy Behav 2007;10:363-76
11. Kotsopoulos IA, van Merode T, Kessels FG, et al. Systematic review and meta-Analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 2002;43:1402-9
12. Bell GS, Sander JW. CPD-education and self-Assessment the epidemiology of epilepsy: The size of the problem. Seizure 2001;10:306-16
13. Carpio A, Hauser WA. Epilepsy in the developing world. Curr Neurol Neurosci Rep 2009;9:319-26
14. Heaney DC, MacDonald BK, Everitt A, et al. Socioeconomic variation in incidence of epilepsy: Prospective community based study in south east England. BMJ 2002;325:1013-6
15. Bartel DP.MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97
16. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007;8:93-103
17. Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell Biol 2007;17:118-26
18. Bentwich I, Avniel A, Karov Y, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005;37:766-70
19. Esquela KA, Slack FJ. OncoMirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69
20. Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004;23:4051-60
21. Provost P, Dishart D, Doucet J, et al. Ribonuclease activity and RNA binding of recombinant human dicer. EMBO J 2002;21:5864-74
22. Lee Y. Ahn C, Choi H, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425:415-9
23. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003;115:209-16
24. Schwarz DS, Hutvagner G, Du T, et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115:199-208
25. Sander JW. The use of antiepileptic drugs-principles and practice. Epilepsia 2004;45:28-34
26. Cascino GD. Epilepsy: Contemporary perspectives on evaluation and treatment. Mayo Clin Proc 1994;69:1199-211
27. Engel J, Jr. Surgery for seizures. N Engl J Med 1996;334:647-52
28. Picot MC, Neveu D, Kahane P, et al. Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy-preliminary results. Rev Neurol (Paris) 2004;160:(5)S354-67
29. Wiebe S, Matijevic S, Eliasziw M, Derry PA. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry 2002;73:116-20
30. McIntosh AM, Kalnins RM, Mitchell LA, et al. Temporal lobectomy: Long-Termseizure outcome, late recurrence and risks for seizure recurrence. Brain 2004;127:2018-30
31. Lhatoo SD, Solomon JK, McEvoy AW, et al. A prospective study of the requirement for and the provision of epilepsy surgery in the United Kingdom. Epilepsia 2003;44:673-6
32. Pichardo-Casas I, Goff LA, Swerdel MR, et al. Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation. Brain Res 2012;1436:20-33
33. McKiernan RC, Jimenez-Mateos EM, Bray I, et al. Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLoS One 2012;7:e35921
34. Hu K, Zhang C, Long L, et al. Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. Neurosci Lett 2011;488:252-7
35. Hu K, Xie YY, Zhang C, et al. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-Targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci 2012;13:115
36. Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, et al. miRNA expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. Am J Pathol 2011;179:2519-32
37. Kan AA, van Erp S, Derijck AA, et al.Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response. Cell Mol Life Sci 2012;69:3127-45
38. Sano T, Reynolds JP, Jimenez-Mateos EM, et al. MicroRNA-34a upregulation during seizure-induced neuronal death. Cell Death Dis 2012;3:e287
39. Nudelman AS, DiRocco DP, Lambert TJ, et al. Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 2010;20:492-8
40. Iyer A, Zurolo E, Prabowo A, et al. MicroRNA-146a: A key regulator of astrocyte-mediated inflammatory response. PLoS One 2012;7:e44789
41. Aronica E, Fluiter K, Iyer A, et al. Expression pattern of miR-146a, an inflammation-Associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 2010;31:1100-7
42. Omran A, Peng J, Zhang C, et al. Interleukin-1β and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy. Epilepsia 2012;53:1215-24
43. Jimenez-Mateos EM, Engel T, Merino-Serrais P, et al. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 2012;18:1087-94
44. Liu DZ, Tian Y, Ander BP, et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 2010;30:92-101
45. Song YJ, Tian XB, Zhang S, et al. Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b. Brain Res 2011;1387:134-40
46. Risbud RM, Lee C, Porter BE. Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus. Brain Res 2011;1424:53-59
47. Boison D. Engineered adenosine-releasing cells for epilepsy therapy: Human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics 2009;6:278-83
48. Bjorklund O, Shang MM, Tonazzini I, et al. Adenosine A(1) and A(3) receptors protect astrocytes from hypoxic damage. Eur J Pharmacol 2008;596:6-13
49. Boison D. Adenosine as a neuromodulator in neurological diseases. Curr Opin Pharmacol 2008;8:2-7
50. Park J, Gupta RS. Adenosine kinase and ribokinase -The RK family of proteins. Cell Mol Life Sci 2008; 65:2875-96
51. Studer FE, Fedele DE, Marowsky A, et al. Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience 2006;142:125-37
52. Ren G, Boison D. Engineering human mesenchymal stem cells to release adenosine using miRNA technology. Methods Mol Biol 2010;650:225-40
53. Aronica E, Boer K, van Vliet EA, et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 2007;26:497-511
54. Aronica E, Gorter J. Gene expression profile in temporal lobe epilepsy. Neuroscientist 2007;13:100-8
55. van Gassen KL, de Wit M, Koerkamp MJ, et al. Possible role of the innate immunity in temporal lobe epilepsy. Epilepsia 2008;49:1055-65
56. Jarvela JT, Lopez-Picon FR, Plysjuk A, et al. Temporal profiles of age-dependent changes in cytokine mRNA expression and glial cell activation after status epilepticus in postnatal rat hippocampus. J Neuroinflammation 2011;8:29
57. Silveira G, de Oliveira AC, Teixeira AL. Insights into inflammation and epilepsy from the basic and clinical sciences. J Clin Neurosci 2012;19:1071-5
58. Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology 2013;69:16-24
59. Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010;32:305-15
60. Viviani B, Bartesaghi S, Gardoni F, et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003;23:8692-700
61. Kan AA, van der Hel WS, Kolk SM, et al. Prolonged increase in rat hippocampal chemokine signalling after status epilepticus. J Neuroimmunol 2012;245:15-22
62. Pearson G, Robinson F, Beers Gibson T, et al. Mitogenactivated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 2001;22:153-83
63. Boison D. Inhibitory RNA in epilepsy: Research tool and therapeutic perspectives. Epilepsia 2010;51:1659-68